JANX
Janux Therapeutics Inc.
$28.80
+$0.21(+0.73%)
55
Overall
60
Value
50
Tech
--
Quality
Market Cap
$1.59B
Volume
795.75K
52W Range
$21.73 - $71.71
Target Price
$81.07
Key Metrics Overview
| Market Cap | $1.59B | P/E Ratio | N/A |
| 52W High | $71.71 | 52W Low | $21.73 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | 2.7% | 52W Position | 14.1% |
| Overall Score | 55 | Value Score | 60 |
| Quality Score | -- | Technical Score | 50 |
Growth Analysis
| EPS Current Est | $-2.06 | EPS Next Est | $-3.06 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | JANX | $28.80 | +0.7% | 795.75K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |